Cardiovascular health in low- and middle-income countries

Insights

Cardiovascular health (CVH) metrics are defined by the American Heart Association. This review examines the current state and strategies for improving CVH in low- and middle-income countries (LMICs).

Area of Science:

  • Public Health
  • Cardiology
  • Global Health

Background:

  • The American Heart Association (AHA) defined cardiovascular health (CVH) using 7 key metrics: 3 health behaviors (diet, physical activity, tobacco use) and 4 health factors (body weight, blood pressure, cholesterol, blood glucose).
  • The AHA aimed to improve CVH by 20% by 2020, emphasizing measurement, monitoring, and messaging.
  • The current status of CVH in low- and middle-income countries (LMICs) remains under-documented.

Purpose of the Study:

  • To review the definition and measurement of CVH.
  • To analyze recent trends in CVH metrics within LMICs.
  • To explore strategies for enhancing CVH in LMICs.

Main Methods:

  • Literature review focusing on CVH definition, measurement, trends, and improvement strategies.
  • Analysis of existing data and research on CVH metrics in LMICs.
  • Synthesis of information on the current state of cardiovascular health behaviors and factors in LMICs.

Main Results:

  • The review outlines the established definition of CVH by the AHA.
  • It discusses methodologies for assessing and tracking CVH in LMICs.
  • Recent trends and potential strategies for improving CVH in these regions are presented.

Conclusions:

  • There is a need for better documentation and understanding of CVH in LMICs.
  • Implementing targeted strategies is crucial for improving cardiovascular health outcomes in these populations.
  • Further research and interventions are required to address the growing burden of cardiovascular disease in LMICs.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K